345 related articles for article (PubMed ID: 25842986)
1. Advances in the treatment of invasive neonatal candidiasis.
Botero-Calderon L; Benjamin DK; Cohen-Wolkowiez M
Expert Opin Pharmacother; 2015 May; 16(7):1035-48. PubMed ID: 25842986
[TBL] [Abstract][Full Text] [Related]
2. Echinocandin use in the neonatal intensive care unit.
Caudle KE; Inger AG; Butler DR; Rogers PD
Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children: A Meta-analysis.
Tsekoura M; Ioannidou M; Pana ZD; Haidich AB; Antachopoulos C; Iosifidis E; Kolios G; Roilides E
Pediatr Infect Dis J; 2019 Jan; 38(1):42-49. PubMed ID: 29596219
[TBL] [Abstract][Full Text] [Related]
4. Invasive fungal infections in newborns and current management strategies.
Hundalani S; Pammi M
Expert Rev Anti Infect Ther; 2013 Jul; 11(7):709-21. PubMed ID: 23829639
[TBL] [Abstract][Full Text] [Related]
5. Old and new: appropriate dosing for neonatal antifungal drugs in the nursery.
Ericson J; Manzoni P; Benjamin DK
Early Hum Dev; 2013 Jun; 89 Suppl 1(0 1):S25-7. PubMed ID: 23809344
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
7. Antifungals in systemic neonatal candidiasis.
Frattarelli DA; Reed MD; Giacoia GP; Aranda JV
Drugs; 2004; 64(9):949-68. PubMed ID: 15101785
[TBL] [Abstract][Full Text] [Related]
8. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
Cross SA; Scott LJ
Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
[TBL] [Abstract][Full Text] [Related]
9. A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis.
Benjamin DK; Kaufman DA; Hope WW; Smith PB; Arrieta A; Manzoni P; Kovanda LL; Lademacher C; Isaacson B; Jednachowski D; Wu C; Kaibara A; Walsh TJ
Pediatr Infect Dis J; 2018 Oct; 37(10):992-998. PubMed ID: 29596222
[TBL] [Abstract][Full Text] [Related]
10. Antifungal agents in neonates: issues and recommendations.
Almirante B; Rodríguez D
Paediatr Drugs; 2007; 9(5):311-21. PubMed ID: 17927303
[TBL] [Abstract][Full Text] [Related]
11. Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin:review of the literature.
Glöckner A
Eur J Med Res; 2011 Apr; 16(4):167-79. PubMed ID: 21486731
[TBL] [Abstract][Full Text] [Related]
12. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
Moen MD; Lyseng-Williamson KA; Scott LJ
Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
[TBL] [Abstract][Full Text] [Related]
13. From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Pea F
Mycoses; 2020 Aug; 63(8):854-858. PubMed ID: 32472719
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
[TBL] [Abstract][Full Text] [Related]
15. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
Montejo M; Quindós G
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
[TBL] [Abstract][Full Text] [Related]
16. [Micafungin for the treatment of neonatal invasive candidiasis].
Infante-López ME; Rojo-Conejo P
Rev Iberoam Micol; 2009 Mar; 26(1):56-61. PubMed ID: 19463278
[TBL] [Abstract][Full Text] [Related]
17. Invasive candidiasis in the ICU: evidence based and on the edge of evidence.
Hollenbach E
Mycoses; 2008 Sep; 51 Suppl 2():25-45. PubMed ID: 18721330
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection.
Lepak AJ; Zhao M; Berkow EL; Lockhart SR; Andes DR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584152
[No Abstract] [Full Text] [Related]
19. Antifungal therapy and outcomes in infants with invasive Candida infections.
Ascher SB; Smith PB; Watt K; Benjamin DK; Cohen-Wolkowiez M; Clark RH; Benjamin DK; Moran C
Pediatr Infect Dis J; 2012 May; 31(5):439-43. PubMed ID: 22189522
[TBL] [Abstract][Full Text] [Related]
20. Neonatal candidiasis: prophylaxis and treatment.
Tiffany KF; Smith PB; Benjamin DK
Expert Opin Pharmacother; 2005 Aug; 6(10):1647-55. PubMed ID: 16086651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]